Kenichi Takayama Selected Research

Toremifene (Fareston)

11/2015

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenichi Takayama Research Topics

Disease

9	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 09/2008
6	Neoplasms (Cancer) 12/2022 - 08/2009
1	Testicular Germ Cell Tumor 01/2013
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2013
1	Carcinogenesis 09/2008

Drug/Important Bio-Agent (IBA)

6	AndrogensIBA 12/2022 - 09/2008
5	Androgen Receptors (Androgen Receptor)IBA 12/2022 - 09/2008
3	Estrogens (Estrogen)FDA Link 01/2018 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 09/2008
1	imidazoleIBA 02/2017
1	Nylons (Nylon)IBA 02/2017
1	PyrrolesIBA 02/2017
1	Testosterone (Sustanon)FDA Link 02/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 11/2015
1	Toremifene (Fareston)FDA Link 11/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2014
1	Biological ProductsIBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	ERRalpha Estrogen-Related ReceptorIBA 03/2010
1	Cytochrome P-450 CYP3AIBA 08/2009
1	Transcription Factors (Transcription Factor)IBA 09/2008
1	Messenger RNA (mRNA)IBA 09/2008
1	Hormones (Hormone)IBA 09/2008
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2008

Therapy/Procedure

4	Therapeutics 12/2022 - 11/2015
3	Castration 01/2020 - 02/2017
1	Precision Medicine 01/2018
1	Orchiectomy (Orchidectomy) 11/2016